EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer modelsPatrizia Porazzi, Marco Ruella, Beatriz M. Carreno et al.|Cancer Cell|2025Cited by 47
CD5 deletion enhances the antitumor activity of adoptive T cell therapiesRuchi P. Patel, Patrizia Porazzi, Stefan K. Barta et al.|Science Immunology|2024Cited by 45